Tenbusch, M., Schumacher, S., Vogel, E., Priller, A., Held, J., Steininger, P., Beileke, S., Irrgang, P., Brockhoff, R., Salmanton-García, J., Tinnefeld, K., Mijocevic, H., Schober, K., Bogdan, C., Yazici, S., Knolle, P., Cornely, O. A., Überla, K., Protzer, U., , , Roggendorf, H., Zelger, O., Christa, C., Jeske, S., Heringer, S., Alsalameh, R., Esse, J., Mattner, J., & Wytopil, M. (2021). heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2. Lancet infectious diseases, 21(9), 1212–1213. http://access.bl.uk/ark:/81055/vdc_100144512846.0x000014